Researchers at University of Utah Health have designed new digital tools that use relevant information from patient health records to prompt doctors to consider lung cancer screening for high-risk patients and provide personalized guidance on screening.
New data highlights two novel proteomic tests that support treatment decision making in patients with non-small cell lung cancer :
Expanded analysis of the VeriStrat® host immune classifier’s.